BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16227680)

  • 1. CD56-positive acute lymphoblastic leukemia.
    Matano S; Terahata S; Nakamura S; Kobayashi K; Sugimoto T
    Acta Haematol; 2005; 114(3):160-3. PubMed ID: 16227680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report.
    Ichinohasama R; Endoh K; Ishizawa K; Okuda M; Kameoka J; Meguro K; Myers J; Kadin ME; Mori S; Sawai T
    Cancer; 1996 Jun; 77(12):2592-603. PubMed ID: 8640711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
    Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
    Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
    Liu XY; Atkins RC; Feusner JH; Rowland JM
    Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia).
    Zhang K; Prichard JW; Brown RE
    Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
    Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
    Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
    Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
    Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
    Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cell lymphoblastic lymphoma in the masticator space: a case of non-Hodgkin lymphoma with challenging maxillofacial manifestation and immunophenotype.
    Imai T; Michizawa M; Degami H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):897-903. PubMed ID: 19846330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis.
    Ogura K; Kimura F; Kobayashi S; Torikai H; Ikeda T; Sato K; Motoyoshi K
    Leuk Res; 2006 Jun; 30(6):761-3. PubMed ID: 16140376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
    Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
    Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
    Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
    Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunophenotypic features in leukemia of NK cell series].
    Ma R; Xu YG; Yang XH; Hu XM; Li L; Tang XD; Zhang SS; Xu S; Wang HZ; Liu F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):35-8. PubMed ID: 16584587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell neoplasms.
    Liang X; Graham DK
    Cancer; 2008 Apr; 112(7):1425-36. PubMed ID: 18286525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient.
    Kawano S; Tatsumi E; Yoneda N; Yamaguchi N; Goji J; Ito H; Nagai T; Nishikori M; Okamura A; Koiwai O
    Hematol Oncol; 1995; 13(1):1-11. PubMed ID: 7538482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.
    Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
    Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.